The benefits of aspirin in acute myocardial infarction. Still a well-kept secret in the United States.
暂无分享,去创建一个
[1] V. Fuster,et al. Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction? , 1993, The Lancet.
[2] P. Vokonas,et al. Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group. , 1993, Circulation.
[3] Eric L. Michelson,et al. Thrombolytic therapy of acute myocardial infarction. Keeping the unfulfilled promises. , 1992 .
[4] G. Lamas,et al. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. , 1992, The New England journal of medicine.
[5] R. Collins,et al. British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. , 1991, British heart journal.
[6] E. J. Brown,et al. Selection Bias in the Use of Thrombolytic Therapy in Acute Myocardial Infarction , 1991 .
[7] R. Collins,et al. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. , 1989, Circulation.